Dr. Johnson, 84, was a pivotal figure in the world of neurology and infectious diseases for much of the past half century. He was the founding Senior Associate Editor for Infectious Diseases of MedLink Neurology
and served on its Editorial Board for more than two decades until his final days.
Read his obituary here
Tributes and memories shared by colleagues on the Editorial Board who knew Dr. Johnson in person:
He was an important figure - a founder of modern Neurology at Johns Hopkins and pioneered global research in tropical neurology and neurovirology. He had a ready smile and a quick wit. He was a person of many talents. He was a key leader of MedLink Neurology. -- Lewis P Rowland MD
Dick Johnson was not only an intellectual giant and a world leader in Neurology, but also an extraordinarily kind and empathetic individual. I will always cherish the times we spent together during my visits to Hopkins, including the time when he desperately tried to find a restaurant that carried crab cakes, even during peak season. He will be missed by so many from and outside of the world of Neurology. -- Joseph Jankovic MD
Dick was a Giant of neurology and a visionary. As a resident, I remember well his teaching and superb command of neurosciences. His Current Therapy book inspired me to edit 4 editions of Current Management in Child Neurology. He touched so many of us and in turn, we pass on his knowledge, values, attitudes and spirit to our trainees. As far as I am concerned Dick Johnson was not only a wonderful person and a gifted leader in neurosciences, Dick Johnson was his own brand! -- Bernie Maria MD
MedLink Corporation is accredited by the ACCME to provide continuing medical education for physicians. Learn more
By mapping the visual responses of fruit flies with different Parkinson genes, biologists at the University of York have built a substantial data bank of results, with which they were able to classify unknown flies as having a Parkinson-related mutation with 85% accuracy. The findings could lead to improved methods of detection for early-onset Parkinson disease.
An infusion of spleen cells coupled with an autoantigen completely prevented experimental autoimmune encephalomyelitis in a mouse model, and the same method also "dramatically reversed" the disease in its early stages, researchers found. The findings were published recently in the Journal of Immunology Research.
A list of U.S. and international meetings, conferences, and symposiums of interest to neurologists.